Concomitant Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

Concomitant Medication
Descrição

Concomitant Medication

Alias
UMLS CUI-1
C2347852
Are there any concomitant medication CHANGES since the start of the study? If "YES", please record all medications below. Where appropriate, medical conditions should be recorded on the Adverse Events Form, utilizing the same terminology. If a medication has had a dosage change it must be recorded with the start and stop date.
Descrição

Concomitant agent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2347852
Concomitant Medication Changes
Descrição

Concomitant Medication Changes

Alias
UMLS CUI-1
C2347852
Drug name (Trade Name preferred)
Descrição

Drug name

Tipo de dados

text

Alias
UMLS CUI [1]
C0013227
SINGLE Dose/ Unit (e.g. 500mg)
Descrição

Single dose/Unit

Tipo de dados

float

Alias
UMLS CUI [1,1]
C2826257
UMLS CUI [1,2]
C1960417
Frequency of this Dose (e.g. BID PRN)
Descrição

Frequency

Tipo de dados

text

Alias
UMLS CUI [1]
C3476109
Route
Descrição

Concomitant Medication Route of Administration

Tipo de dados

text

Alias
UMLS CUI [1]
C2826730
Indication
Descrição

Indication

Tipo de dados

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C3146298
Start Date/Time
Descrição

Start Date Time

Tipo de dados

datetime

Alias
UMLS CUI [1]
C2827019
End Date/Time
Descrição

Stop Date

Tipo de dados

datetime

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0806020
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C1522314
Continuing at end of Study?
Descrição

Continuing at end of study

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1553904

Similar models

Concomitant Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Concomitant Medication
C2347852 (UMLS CUI-1)
Concomitant agent
Item
Are there any concomitant medication CHANGES since the start of the study? If "YES", please record all medications below. Where appropriate, medical conditions should be recorded on the Adverse Events Form, utilizing the same terminology. If a medication has had a dosage change it must be recorded with the start and stop date.
boolean
C2347852 (UMLS CUI [1])
Item Group
Concomitant Medication Changes
C2347852 (UMLS CUI-1)
Drug name
Item
Drug name (Trade Name preferred)
text
C0013227 (UMLS CUI [1])
Single dose/Unit
Item
SINGLE Dose/ Unit (e.g. 500mg)
float
C2826257 (UMLS CUI [1,1])
C1960417 (UMLS CUI [1,2])
Frequency
Item
Frequency of this Dose (e.g. BID PRN)
text
C3476109 (UMLS CUI [1])
Concomitant Medication Route of Administration
Item
Route
text
C2826730 (UMLS CUI [1])
Indication
Item
Indication
text
C2347852 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
Start Date Time
Item
Start Date/Time
datetime
C2827019 (UMLS CUI [1])
Stop Date
Item
End Date/Time
datetime
C0013227 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C1522314 (UMLS CUI [2,2])
Continuing at end of study
Item
Continuing at end of Study?
boolean
C1553904 (UMLS CUI [1])